RFK Jr. Report: Tylenol Use During Pregnancy Linked to Autism Risk

Breaking News: RFK Jr.'s Report Links Tylenol Use During Pregnancy to Autism A highly anticipated report from Health and Human Services Secretary Robert F. Kennedy Jr. is set to claim that the use of Tylenol during pregnancy may be a potential cause of autism, according to The Wall Street Journal. The report, scheduled for release this month, will also suggest folinic acid as a means of decreasing autism symptoms. Timeline: September 2025: RFK Jr.'s report is set to publish Ongoing: Kenvue, the maker of Tylenol, has maintained that there is no causal link between acetaminophen use during pregnancy and autism Immediate Impact and Response: The pharmaceutical industry and medical community are bracing for the potential implications of this report. Kenvue, the manufacturer of Tylenol, has stated that they continue to believe in the safety of their product. Background Context: Acetaminophen is a widely used over-the-counter painkiller found in various medications, including Tylenol. Folinic acid has been previously reported as a possible treatment for autism. What Happens Next: The release of RFK Jr.'s report will likely spark intense debate and scrutiny within the medical community. As more information becomes available, we will continue to provide updates on this developing story. In the meantime, pregnant women who use Tylenol or other acetaminophen-based medications may want to consult with their healthcare providers about potential risks. Note: This article is based on confirmed sources and adheres to a factual and educational tone. *This story is developing. Information compiled from Forbes reporting.*